Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Insulet Corporation chart...

About the Company

insulet corporation is an innovative medical device company based in billerica, massachusetts. it was founded in 2000 with the mission of improving the lives of people with diabetes. specifically, through its revolutionary omnipod insulin management system, insulet seeks to expand the use of insulin pump therapy. studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (mdi); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. despite these benefits, most people still choose mdi therapy largely due to the complexity, cost and inconvenience of conventional pump technology. the omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. improvements include omnipod's lack of tubing; automated, virtually pain-free insertion; and two straightforward parts that communicate wirelessly. by breaking down

CEO

Shacey Petrovic

Exchange

NASDAQ

Website

https://www.myomnipod.com/

$2B

Total Revenue

2K

Employees

$12B

Market Capitalization

74.32

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PODD News

Here's Why Insulet (PODD) Detracted in Q4

9d ago, source: InvestingChannel on MSN

In addition, please check the fund's top five holdings to know its best picks in 2023. ClearBridge Aggressive Growth Strategy ...

Here's Why You Should Buy Insulet (PODD) Stock Right Now

10d ago, source: Zacks.com on MSN

Insulet Corporation PODD is well-poised to gain in the coming quarters, backed by the strength of its revolutionary Omnipod 5 Automated Insulin Delivery (“AID”) system. The continued market expansion ...

Insulet Appoints Ana Maria Chadwick as Chief Financial Officer

8d ago, source:

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

Insulet Names Ana Maria Chadwick CFO, Effective April 22

8d ago, source:

Medical device company Insulet Corp. (PODD) announced Wednesday that it has appointed Ana Maria Chadwick as Executive Vice President, ...

Insulet’s Growth Trajectory Affirmed with a Buy Rating and Revised Target Price

12d ago, source:

Citi analyst Joanne Wuensch has reiterated their bullish stance on PODD stock, giving a Buy rating on March 6. Joanne Wuensch’s rating ...

Insulet's Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy

20d ago, source: Stockhouse

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented positive results from ...

Insulet appoints new CFO to bolster leadership team

8d ago, source: Investing

ACTON, Mass. - Insulet (NASDAQ:PODD) Corporation (NASDAQ: PODD), a leading medical device company known for its tubeless insulin pump technology, announced the appointment of Ana Maria Chadwick as ...

Insulet Corp.

20d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Insulet Appoints Ana Maria Chadwick as Chief Financial Officer

8d ago, source: Morningstar

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Ana Maria Chadwick has ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...